Verapamil Hydrochloride Tablet
Product Images NDC 70518-4513

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Verapamil Hydrochloride (NDC 70518-4513). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
This is a description of Verapamil HCI Extended-Release Tablet in 180 mg strength with a quantity of 90 tablets. The oval-shaped blue tablet is repackaged by RemedyRepack Inc. and has a LOT# and original NDC mentioned on the packaging. The manufacturer is Nivagen Pharmaceuticals. The usual dosage instructions can be found in the insert. It is recommended to keep the medication out of reach of children and store it at a temperature between 20-25°C (68-77°F) with excursions permitted to 15-30°C (59-86°F) as per USP guidelines.*
FDA Label Image

Structure.jpg (Structure)

Structure.jpg (Structure)
This text contains chemical information about a compound with the molecular formula C27H38N204 - HCI and a molecular weight of 491.08 g/mol. The compound is named Benzeneacetonitrile, a-[3-[[2-(3,4-dimethoxyphenyl)ethyl]methylamino] propyl]-3,4-dimethoxy-a-(1-methylethyl) hydrochloride. It involves various functional groups such as CH, OCH, CHz, NCHzCHz OCH, HCI, and CH(CH).*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.